Global and United States Subcutaneous Injection Market Report & Forecast 2023-2028

Report ID: 1841804 | Published Date: Jan 2025 | No. of Page: 98 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
1 Study Coverage
    1.1 Subcutaneous Injection Revenue in Subcutaneous Injection Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Subcutaneous Injection Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Subcutaneous Injection Market Size for the Year 2017-2028
        1.2.2 Global Subcutaneous Injection Market Size for the Year 2017-2028
    1.3 Subcutaneous Injection Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Subcutaneous Injection in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Subcutaneous Injection Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Subcutaneous Injection Market Dynamics
        1.4.1 Subcutaneous Injection Industry Trends
        1.4.2 Subcutaneous Injection Market Drivers
        1.4.3 Subcutaneous Injection Market Challenges
        1.4.4 Subcutaneous Injection Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Subcutaneous Injection by Type
    2.1 Subcutaneous Injection Market Segment by Type
        2.1.1 Subcutaneous Injection Equipment
        2.1.2 Subcutaneous Injection Drug
        2.1.3 Others
    2.2 Global Subcutaneous Injection Market Size by Type (2017, 2022 & 2028)
    2.3 Global Subcutaneous Injection Market Size by Type (2017-2028)
    2.4 United States Subcutaneous Injection Market Size by Type (2017, 2022 & 2028)
    2.5 United States Subcutaneous Injection Market Size by Type (2017-2028)
3 Subcutaneous Injection by Application
    3.1 Subcutaneous Injection Market Segment by Application
        3.1.1 Hospital
        3.1.2 Clinic
        3.1.3 Laboratory
        3.1.4 Others
    3.2 Global Subcutaneous Injection Market Size by Application (2017, 2022 & 2028)
    3.3 Global Subcutaneous Injection Market Size by Application (2017-2028)
    3.4 United States Subcutaneous Injection Market Size by Application (2017, 2022 & 2028)
    3.5 United States Subcutaneous Injection Market Size by Application (2017-2028)
4 Global Subcutaneous Injection Competitor Landscape by Company
    4.1 Global Subcutaneous Injection Market Size by Company
        4.1.1 Top Global Subcutaneous Injection Companies Ranked by Revenue (2021)
        4.1.2 Global Subcutaneous Injection Revenue by Player (2017-2022)
    4.2 Global Subcutaneous Injection Concentration Ratio (CR)
        4.2.1 Subcutaneous Injection Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Subcutaneous Injection in 2021
        4.2.3 Global Subcutaneous Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Subcutaneous Injection Headquarters, Revenue in Subcutaneous Injection Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Subcutaneous Injection Headquarters and Area Served
        4.3.2 Global Subcutaneous Injection Companies Revenue in Subcutaneous Injection Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Subcutaneous Injection Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Subcutaneous Injection Market Size by Company
        4.5.1 Top Subcutaneous Injection Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Subcutaneous Injection Revenue by Players (2020, 2021 & 2022)
5 Global Subcutaneous Injection Market Size by Region
    5.1 Global Subcutaneous Injection Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Subcutaneous Injection Market Size by Region (2017-2028)
        5.2.1 Global Subcutaneous Injection Market Size by Region: 2017-2022
        5.2.2 Global Subcutaneous Injection Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Subcutaneous Injection Market Size YoY Growth 2017-2028
        6.1.2 North America Subcutaneous Injection Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Subcutaneous Injection Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Subcutaneous Injection Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Subcutaneous Injection Market Size YoY Growth 2017-2028
        6.3.2 Europe Subcutaneous Injection Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Subcutaneous Injection Market Size YoY Growth 2017-2028
        6.4.2 Latin America Subcutaneous Injection Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Subcutaneous Injection Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Subcutaneous Injection Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE
7 Company Profiles
    7.1 Becton Dickinson
        7.1.1 Becton Dickinson Company Details
        7.1.2 Becton Dickinson Business Overview
        7.1.3 Becton Dickinson Subcutaneous Injection Introduction
        7.1.4 Becton Dickinson Revenue in Subcutaneous Injection Business (2017-2022)
        7.1.5 Becton Dickinson Recent Development
    7.2 Daiichi Sankyo
        7.2.1 Daiichi Sankyo Company Details
        7.2.2 Daiichi Sankyo Business Overview
        7.2.3 Daiichi Sankyo Subcutaneous Injection Introduction
        7.2.4 Daiichi Sankyo Revenue in Subcutaneous Injection Business (2017-2022)
        7.2.5 Daiichi Sankyo Recent Development
    7.3 Sanofi
        7.3.1 Sanofi Company Details
        7.3.2 Sanofi Business Overview
        7.3.3 Sanofi Subcutaneous Injection Introduction
        7.3.4 Sanofi Revenue in Subcutaneous Injection Business (2017-2022)
        7.3.5 Sanofi Recent Development
    7.4 Roche
        7.4.1 Roche Company Details
        7.4.2 Roche Business Overview
        7.4.3 Roche Subcutaneous Injection Introduction
        7.4.4 Roche Revenue in Subcutaneous Injection Business (2017-2022)
        7.4.5 Roche Recent Development
    7.5 GSK
        7.5.1 GSK Company Details
        7.5.2 GSK Business Overview
        7.5.3 GSK Subcutaneous Injection Introduction
        7.5.4 GSK Revenue in Subcutaneous Injection Business (2017-2022)
        7.5.5 GSK Recent Development
    7.6 Eli Lilly
        7.6.1 Eli Lilly Company Details
        7.6.2 Eli Lilly Business Overview
        7.6.3 Eli Lilly Subcutaneous Injection Introduction
        7.6.4 Eli Lilly Revenue in Subcutaneous Injection Business (2017-2022)
        7.6.5 Eli Lilly Recent Development
    7.7 Asahi Kasei Pharma
        7.7.1 Asahi Kasei Pharma Company Details
        7.7.2 Asahi Kasei Pharma Business Overview
        7.7.3 Asahi Kasei Pharma Subcutaneous Injection Introduction
        7.7.4 Asahi Kasei Pharma Revenue in Subcutaneous Injection Business (2017-2022)
        7.7.5 Asahi Kasei Pharma Recent Development
    7.8 Takeda Pharmaceutical
        7.8.1 Takeda Pharmaceutical Company Details
        7.8.2 Takeda Pharmaceutical Business Overview
        7.8.3 Takeda Pharmaceutical Subcutaneous Injection Introduction
        7.8.4 Takeda Pharmaceutical Revenue in Subcutaneous Injection Business (2017-2022)
        7.8.5 Takeda Pharmaceutical Recent Development
    7.9 Antares Pharma, Inc.
        7.9.1 Antares Pharma, Inc. Company Details
        7.9.2 Antares Pharma, Inc. Business Overview
        7.9.3 Antares Pharma, Inc. Subcutaneous Injection Introduction
        7.9.4 Antares Pharma, Inc. Revenue in Subcutaneous Injection Business (2017-2022)
        7.9.5 Antares Pharma, Inc. Recent Development
    7.10 Eisai Co.,Ltd
        7.10.1 Eisai Co.,Ltd Company Details
        7.10.2 Eisai Co.,Ltd Business Overview
        7.10.3 Eisai Co.,Ltd Subcutaneous Injection Introduction
        7.10.4 Eisai Co.,Ltd Revenue in Subcutaneous Injection Business (2017-2022)
        7.10.5 Eisai Co.,Ltd Recent Development
    7.11 Chugai Pharmaceutical
        7.11.1 Chugai Pharmaceutical Company Details
        7.11.2 Chugai Pharmaceutical Business Overview
        7.11.3 Chugai Pharmaceutical Subcutaneous Injection Introduction
        7.11.4 Chugai Pharmaceutical Revenue in Subcutaneous Injection Business (2017-2022)
        7.11.5 Chugai Pharmaceutical Recent Development
    7.12 Endo International
        7.12.1 Endo International Company Details
        7.12.2 Endo International Business Overview
        7.12.3 Endo International Subcutaneous Injection Introduction
        7.12.4 Endo International Revenue in Subcutaneous Injection Business (2017-2022)
        7.12.5 Endo International Recent Development
    7.13 PenJet Corporation
        7.13.1 PenJet Corporation Company Details
        7.13.2 PenJet Corporation Business Overview
        7.13.3 PenJet Corporation Subcutaneous Injection Introduction
        7.13.4 PenJet Corporation Revenue in Subcutaneous Injection Business (2017-2022)
        7.13.5 PenJet Corporation Recent Development
    7.14 Aspen Medical Group
        7.14.1 Aspen Medical Group Company Details
        7.14.2 Aspen Medical Group Business Overview
        7.14.3 Aspen Medical Group Subcutaneous Injection Introduction
        7.14.4 Aspen Medical Group Revenue in Subcutaneous Injection Business (2017-2022)
        7.14.5 Aspen Medical Group Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer
List of Tables
    Table 1. Subcutaneous Injection Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Subcutaneous Injection Market Trends
    Table 3. Subcutaneous Injection Market Drivers
    Table 4. Subcutaneous Injection Market Challenges
    Table 5. Subcutaneous Injection Market Restraints
    Table 6. Global Subcutaneous Injection Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Subcutaneous Injection Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Subcutaneous Injection Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Subcutaneous Injection Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Subcutaneous Injection Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Subcutaneous Injection Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Subcutaneous Injection Revenue Share by Player, 2017-2022
    Table 13. Global Subcutaneous Injection Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Subcutaneous Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Subcutaneous Injection as of 2021)
    Table 15. Top Players of Subcutaneous Injection in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Subcutaneous Injection Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Subcutaneous Injection Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Subcutaneous Injection Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Subcutaneous Injection Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Subcutaneous Injection Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Subcutaneous Injection Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Subcutaneous Injection Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Subcutaneous Injection Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Subcutaneous Injection Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Subcutaneous Injection Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Subcutaneous Injection Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Subcutaneous Injection Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Subcutaneous Injection Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Becton Dickinson Company Details
    Table 31. Becton Dickinson Business Overview
    Table 32. Becton Dickinson Subcutaneous Injection Product
    Table 33. Becton Dickinson Revenue in Subcutaneous Injection Business (2017-2022) & (US$ Million)
    Table 34. Becton Dickinson Recent Development
    Table 35. Daiichi Sankyo Company Details
    Table 36. Daiichi Sankyo Business Overview
    Table 37. Daiichi Sankyo Subcutaneous Injection Product
    Table 38. Daiichi Sankyo Revenue in Subcutaneous Injection Business (2017-2022) & (US$ Million)
    Table 39. Daiichi Sankyo Recent Development
    Table 40. Sanofi Company Details
    Table 41. Sanofi Business Overview
    Table 42. Sanofi Subcutaneous Injection Product
    Table 43. Sanofi Revenue in Subcutaneous Injection Business (2017-2022) & (US$ Million)
    Table 44. Sanofi Recent Development
    Table 45. Roche Company Details
    Table 46. Roche Business Overview
    Table 47. Roche Subcutaneous Injection Product
    Table 48. Roche Revenue in Subcutaneous Injection Business (2017-2022) & (US$ Million)
    Table 49. Roche Recent Development
    Table 50. GSK Company Details
    Table 51. GSK Business Overview
    Table 52. GSK Subcutaneous Injection Product
    Table 53. GSK Revenue in Subcutaneous Injection Business (2017-2022) & (US$ Million)
    Table 54. GSK Recent Development
    Table 55. Eli Lilly Company Details
    Table 56. Eli Lilly Business Overview
    Table 57. Eli Lilly Subcutaneous Injection Product
    Table 58. Eli Lilly Revenue in Subcutaneous Injection Business (2017-2022) & (US$ Million)
    Table 59. Eli Lilly Recent Development
    Table 60. Asahi Kasei Pharma Company Details
    Table 61. Asahi Kasei Pharma Business Overview
    Table 62. Asahi Kasei Pharma Subcutaneous Injection Product
    Table 63. Asahi Kasei Pharma Revenue in Subcutaneous Injection Business (2017-2022) & (US$ Million)
    Table 64. Asahi Kasei Pharma Recent Development
    Table 65. Takeda Pharmaceutical Company Details
    Table 66. Takeda Pharmaceutical Business Overview
    Table 67. Takeda Pharmaceutical Subcutaneous Injection Product
    Table 68. Takeda Pharmaceutical Revenue in Subcutaneous Injection Business (2017-2022) & (US$ Million)
    Table 69. Takeda Pharmaceutical Recent Development
    Table 70. Antares Pharma, Inc. Company Details
    Table 71. Antares Pharma, Inc. Business Overview
    Table 72. Antares Pharma, Inc. Subcutaneous Injection Product
    Table 73. Antares Pharma, Inc. Revenue in Subcutaneous Injection Business (2017-2022) & (US$ Million)
    Table 74. Antares Pharma, Inc. Recent Development
    Table 75. Eisai Co.,Ltd Company Details
    Table 76. Eisai Co.,Ltd Business Overview
    Table 77. Eisai Co.,Ltd Subcutaneous Injection Product
    Table 78. Eisai Co.,Ltd Revenue in Subcutaneous Injection Business (2017-2022) & (US$ Million)
    Table 79. Eisai Co.,Ltd Recent Development
    Table 80. Chugai Pharmaceutical Company Details
    Table 81. Chugai Pharmaceutical Business Overview
    Table 82. Chugai Pharmaceutical Subcutaneous Injection Product
    Table 83. Chugai Pharmaceutical Revenue in Subcutaneous Injection Business (2017-2022) & (US$ Million)
    Table 84. Chugai Pharmaceutical Recent Development
    Table 85. Endo International Company Details
    Table 86. Endo International Business Overview
    Table 87. Endo International Subcutaneous Injection Product
    Table 88. Endo International Revenue in Subcutaneous Injection Business (2017-2022) & (US$ Million)
    Table 89. Endo International Recent Development
    Table 90. PenJet Corporation Company Details
    Table 91. PenJet Corporation Business Overview
    Table 92. PenJet Corporation Subcutaneous Injection Product
    Table 93. PenJet Corporation Revenue in Subcutaneous Injection Business (2017-2022) & (US$ Million)
    Table 94. PenJet Corporation Recent Development
    Table 95. Aspen Medical Group Company Details
    Table 96. Aspen Medical Group Business Overview
    Table 97. Aspen Medical Group Subcutaneous Injection Product
    Table 98. Aspen Medical Group Revenue in Subcutaneous Injection Business (2017-2022) & (US$ Million)
    Table 99. Aspen Medical Group Recent Development
    Table 100. Research Programs/Design for This Report
    Table 101. Key Data Information from Secondary Sources
    Table 102. Key Data Information from Primary Sources
List of Figures
    Figure 1. Subcutaneous Injection Product Picture
    Figure 2. Global Subcutaneous Injection Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Subcutaneous Injection Market Size 2017-2028 (US$ Million)
    Figure 4. United States Subcutaneous Injection Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Subcutaneous Injection Market Size 2017-2028 (US$ Million)
    Figure 6. United States Subcutaneous Injection Market Share in Global 2017-2028
    Figure 7. Subcutaneous Injection Report Years Considered
    Figure 8. Product Picture of Subcutaneous Injection Equipment
    Figure 9. Product Picture of Subcutaneous Injection Drug
    Figure 10. Product Picture of Others
    Figure 11. Global Subcutaneous Injection Market Share by Type in 2022 & 2028
    Figure 12. Global Subcutaneous Injection Market Size by Type (2017-2028) & (US$ Million)
    Figure 13. Global Subcutaneous Injection Market Share by Type (2017-2028)
    Figure 14. United States Subcutaneous Injection Market Share by Type in 2022 & 2028
    Figure 15. United States Subcutaneous Injection Market Size by Type (2017-2028) & (US$ Million)
    Figure 16. United States Subcutaneous Injection Market Share by Type (2017-2028)
    Figure 17. Product Picture of Hospital
    Figure 18. Product Picture of Clinic
    Figure 19. Product Picture of Laboratory
    Figure 20. Product Picture of Others
    Figure 21. Global Subcutaneous Injection Market Share by Application in 2022 & 2028
    Figure 22. Global Subcutaneous Injection Market Size by Application (2017-2028) & (US$ Million)
    Figure 23. Global Subcutaneous Injection Market Share by Application (2017-2028)
    Figure 24. United States Subcutaneous Injection Market Share by Application in 2022 & 2028
    Figure 25. United States Subcutaneous Injection Market Size by Application (2017-2028) & (US$ Million)
    Figure 26. United States Subcutaneous Injection Market Share by Application (2017-2028)
    Figure 27. North America Subcutaneous Injection Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 28. U.S. Subcutaneous Injection Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. Canada Subcutaneous Injection Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. Europe Subcutaneous Injection Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 31. Germany Subcutaneous Injection Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. France Subcutaneous Injection Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. U.K. Subcutaneous Injection Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Italy Subcutaneous Injection Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Russia Subcutaneous Injection Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Asia-Pacific Subcutaneous Injection Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 37. China Subcutaneous Injection Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Japan Subcutaneous Injection Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. South Korea Subcutaneous Injection Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. India Subcutaneous Injection Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Australia Subcutaneous Injection Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Taiwan Subcutaneous Injection Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Indonesia Subcutaneous Injection Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Thailand Subcutaneous Injection Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Malaysia Subcutaneous Injection Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Philippines Subcutaneous Injection Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Latin America Subcutaneous Injection Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 48. Mexico Subcutaneous Injection Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Brazil Subcutaneous Injection Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Argentina Subcutaneous Injection Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Middle East & Africa Subcutaneous Injection Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 52. Turkey Subcutaneous Injection Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia Subcutaneous Injection Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. UAE Subcutaneous Injection Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Becton Dickinson Revenue Growth Rate in Subcutaneous Injection Business (2017-2022)
    Figure 56. Daiichi Sankyo Revenue Growth Rate in Subcutaneous Injection Business (2017-2022)
    Figure 57. Sanofi Revenue Growth Rate in Subcutaneous Injection Business (2017-2022)
    Figure 58. Roche Revenue Growth Rate in Subcutaneous Injection Business (2017-2022)
    Figure 59. GSK Revenue Growth Rate in Subcutaneous Injection Business (2017-2022)
    Figure 60. Eli Lilly Revenue Growth Rate in Subcutaneous Injection Business (2017-2022)
    Figure 61. Asahi Kasei Pharma Revenue Growth Rate in Subcutaneous Injection Business (2017-2022)
    Figure 62. Takeda Pharmaceutical Revenue Growth Rate in Subcutaneous Injection Business (2017-2022)
    Figure 63. Antares Pharma, Inc. Revenue Growth Rate in Subcutaneous Injection Business (2017-2022)
    Figure 64. Eisai Co.,Ltd Revenue Growth Rate in Subcutaneous Injection Business (2017-2022)
    Figure 65. Chugai Pharmaceutical Revenue Growth Rate in Subcutaneous Injection Business (2017-2022)
    Figure 66. Endo International Revenue Growth Rate in Subcutaneous Injection Business (2017-2022)
    Figure 67. PenJet Corporation Revenue Growth Rate in Subcutaneous Injection Business (2017-2022)
    Figure 68. Aspen Medical Group Revenue Growth Rate in Subcutaneous Injection Business (2017-2022)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Becton Dickinson
Daiichi Sankyo
Sanofi
Roche
GSK
Eli Lilly
Asahi Kasei Pharma
Takeda Pharmaceutical
Antares Pharma, Inc.
Eisai Co.,Ltd
Chugai Pharmaceutical
Endo International
PenJet Corporation
Aspen Medical Group
Frequently Asked Questions
Subcutaneous Injection report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Subcutaneous Injection report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Subcutaneous Injection report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Solar Control Films

Solar Control Films market is segmented by region (country), players, by Type and by Application. ... Read More